Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M31.7Revenue $M0.2Net Margin (%)-408,960.0Altman Z-Score1.8
Enterprise Value $M31.6EPS $-1.2Operating Margin %-413,720.0Piotroski F-Score4
P/E(ttm)--Beneish M-Score--Pre-tax Margin (%)-408,960.0Higher ROA y-yN
Price/Book1.810-y EBITDA Growth Rate %--Quick Ratio0.1Cash flow > EarningsY
Price/Sales--5-y EBITDA Growth Rate %--Current Ratio0.1Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-124.7Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-135.6Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M28.8ROIC % (ttm)-137.8Gross Margin Increase y-yY

Gurus Latest Trades with IMCL

Number of guru portfolios checked: 68.
No Entry found in the selected group of Gurus. You can

IMCL is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


IMCL: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
ICAHN CARL CDirector, 10% Owner 2008-11-21Sell11,669,544$70-98.43 view
CROWLEY RichardSVP, Biopharmaceutical Ops 2008-11-03Sell11,957$68.72-98.4 view
CROWLEY RichardSVP, Biopharmaceutical Ops 2008-09-02Sell11,957$64.4-98.29 view
CROWLEY RichardSVP, Biopharmaceutical Ops 2007-11-19Sell9,150$42.65-97.42 view
BAILEY MICHAEL PSVP, Commercial Ops 2007-11-19Sell14,750$64.16-98.29 view
CROWLEY RichardSVP, Biopharmaceutical Ops 2007-11-19Sell26,957$64.16-98.29 view
Johnson John HCEO 2007-09-07Buy13,609$36.74-97.01 view
BAILEY MICHAEL PSVP, Commercial Ops 2007-07-12Sell1,250$34.2-96.78 view
RAMANATHAN ERIKSenior Vice President, Legal 2006-10-13Sell9,996$30.9-96.44 view
RAMANATHAN ERIKSenior Vice President, Legal 2006-10-10Sell5,004$30.92-96.44 view

Quarterly/Annual Reports about IMCL:

News about IMCL:

Articles On GuruFocus.com
No related article found.

More From Other Websites
IMMUNOCLIN CORP Financials Jun 30 2015
IMMUNOCLIN CORP Financials Jun 03 2015
Linking cancer drug prices to their performance May 27 2015
ImmunoClin Ltd. to Provide Contract Research Organization (CRO) Services for Crotoxin Phase I Part... May 20 2015
Subsidiary of ImmunoClin Corporation (IMCL) receives controlled drug license in the United Kingdom Apr 02 2015
Activist investor at Ariad Pharmaceuticals has long history of wins Mar 11 2015
ImmunoClin Corporation (IMCL) Relocates European Headquarters and Laboratories to London, UK Mar 10 2015
Activists want 'imminent retirement' of Ariad CEO Feb 20 2015
IMMUNOCLIN CORP Files SEC form 10-Q, Quarterly Report Dec 22 2014
Cannabis Science Announces Corporate Changes, Appointing Raymond Dabney As President And CEO And Dr.... Nov 06 2014
IMMUNOCLIN CORP Files SEC form 10-Q, Quarterly Report Sep 29 2014
Cannabis Science, Inc. (CBIS) Signs Drug Development and Laboratory Services Agreement with... Sep 29 2014
ImmunoClin Corporation (IMCL) Announces the Appointment of Infectious Disease Expert, Dr. Heinz... Aug 05 2014
IMMUNOCLIN CORP Files SEC form 8-K, Other Events Aug 01 2014
ImmunoClin Corporation (IMCL) Relocates Corporate Headquarters to Washington, DC Jul 29 2014
IMMUNOCLIN CORP Files SEC form 10-Q, Quarterly Report Jul 24 2014
IMMUNOCLIN CORP Files SEC form 8-K, Changes in Registrant's Certifying Accountant, Financial... Jul 08 2014

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK